Skip to content
SentinelMarket desk
Switch to dark mode

킵스파마

256940KOSDAQView the 제약 sectorTheme Bio & healthcare

5,620KRWMarket close of 10/21 (Wed)

Down -2.94%-170KRWMarket close of 10/21 (Wed)

Open
5,720
High
5,840
Low
5,540
Day range
Day range low 5,540 high 5,840, open 5,720, close 5,620, previous close 5,790
Volume
3×10K shares
153.03 million KRW 0.47× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 5,320 to 12,450 won, 4% up from the low

4% of the way up from the lowest close in 1 year (252 sessions) · -54.9% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-2.94%-2.94%, 1.0× the usual (20-session average ±2.86%)
    That day -2.94% · usual ±2.86% · large-move threshold ±5.7%

The other 3 are within the usual range

  • Trading value0.5×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue59.4B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +46.2%
    vs. prior quarter
    +31.4%
  • Operating income-663.57 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned to loss
    vs. prior quarter
    Turned to loss
  • Operating margin-1.1%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -1.3 pp
    vs. prior quarter
    -3.4 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15
2021Q1 -1.5B KRW2026Q1 -663.57 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.